EP2662094
Sýklódextrín-flókabindingaraðferðir til að formúlera peptíð-meltikornahindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.5.2013EP published:
17.4.2024EP application number:
13167148.9
EP translation filed:
10.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
7.5.2033Expiry date:
7.5.2026Next due date:
31.5.2026
Title in English:
Cylodextrin Complexation Methods for Formulating Peptide Proteasome InhibitorsLanguage of the patent:
English
Timeline
Today
8.5.2013EP application
17.4.2024EP Publication
10.6.2024Translation submitted
15.7.2024Registration published
7.5.2026Expires
Owner
Name:
Onyx Therapeutics, Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
Lewis, EvanAddress:
Pacifica, CA California 64044, US
Name:
Shwonek, PeterAddress:
San Francisco, CA California 94112, US
Name:
Dalziel, SeanAddress:
San Francisco, CA California 94105, US
Name:
Jumaa, MouhannadAddress:
Foster City, CA California 94404, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261644122 PDate:
8.5.2012Country:
US
Number:
201361777475 PDate:
12.3.2013Country:
US
Classification
Categories:
A61K 47/69, A61K 38/07, B82Y 5/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 21.5.2024
Expires: 7.5.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.5.2025
Expires: 7.5.2026
Payer: Árnason Faktor ehf.